A Study of mRNA Encoding CD19/CD3 T Cell Engager (ABO2203) in Patients With Refractory Autoimmune Diseases
Abroad (travel likely)RecruitingEARLY_PHASE1
Conditions
Autoimmune Diseases
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China
Contact: Study coordinator (Chunli Mei, MD)Contact: Principal Investigator (Anbin Huang)Nanjing Drum Tower Hospital, Nanjing, Jiangsu, China
Contact: Study coordinator (Yulin Geng, MD)Contact: Principal Investigator (Lingyun Sun, MD)Ruijin Hospital, Shanghai, China
Contact: Principal Investigator (Chengde Yang)
Study leads
Chengde Yang
Principal Investigator
Ruijin Hospital